| Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis NB Finnerup, N Attal, S Haroutounian, E McNicol, R Baron, RH Dworkin, ... The Lancet Neurology 14 (2), 162-173, 2015 | 5123 | 2015 |
| Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) D Bouhassira, N Attal, H Alchaar, F Boureau, B Brochet, J Bruxelle, ... pain 114 (1-2), 29-36, 2005 | 3513 | 2005 |
| Neuropathic pain L Colloca, T Ludman, D Bouhassira, R Baron, AH Dickenson, D Yarnitsky, ... Nature reviews Disease primers 3 (1), 1-19, 2017 | 2872 | 2017 |
| Prevalence of chronic pain with neuropathic characteristics in the general population D Bouhassira, M Lantéri-Minet, N Attal, B Laurent, C Touboul Pain 136 (3), 380-387, 2008 | 2336 | 2008 |
| Development and validation of the neuropathic pain symptom inventory D Bouhassira, N Attal, J Fermanian, H Alchaar, M Gautron, E Masquelier, ... Pain 108 (3), 248-257, 2004 | 1591 | 2004 |
| EFNS guidelines on pharmacological treatment of neuropathic pain N Attal, G Cruccu, M Haanpää, P Hansson, TS Jensen, T Nurmikko, ... European journal of neurology 13 (11), 1153-1169, 2006 | 1505 | 2006 |
| NeuPSIG guidelines on neuropathic pain assessment M Haanpää, N Attal, M Backonja, R Baron, M Bennett, D Bouhassira, ... PAIN® 152 (1), 14-27, 2011 | 1431 | 2011 |
| The IASP classification of chronic pain for ICD-11: chronic neuropathic pain J Scholz, NB Finnerup, N Attal, Q Aziz, R Baron, MI Bennett, R Benoliel, ... Pain 160 (1), 53-59, 2019 | 1295 | 2019 |
| Using screening tools to identify neuropathic pain MI Bennett, N Attal, MM Backonja, R Baron, D Bouhassira, R Freynhagen, ... Pain 127 (3), 199-203, 2007 | 809 | 2007 |
| EFNS guidelines on neuropathic pain assessment G Cruccu, P Anand, N Attal, L Garcia‐Larrea, M Haanpää, E Jørum, ... European journal of neurology 11 (3), 153-162, 2004 | 764 | 2004 |
| EFNS guidelines on neuropathic pain assessment: revised 2009 G Cruccu, C Sommer, P Anand, N Attal, R Baron, L Garcia‐Larrea, ... European journal of neurology 17 (8), 1010-1018, 2010 | 735 | 2010 |
| Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus N Attal, R Baron, D Bouhassira, M Drangholt, PJ Dyck, RR Edwards, ... PAIN® 154 (9), 1807-1819, 2013 | 682 | 2013 |
| Further evidence for ‘pain-related’behaviours in a model of unilateral peripheral mononeuropathy N Attal, F Jazat, V Kayser, G Guilbaud Pain 41 (2), 235-251, 1990 | 674 | 1990 |
| Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles R Baron, C Maier, N Attal, A Binder, D Bouhassira, G Cruccu, ... Pain 158 (2), 261-272, 2017 | 667 | 2017 |
| The specific disease burden of neuropathic pain: results of a French nationwide survey N Attal, M Lanteri-Minet, B Laurent, J Fermanian, D Bouhassira Pain 152 (12), 2836-2843, 2011 | 564 | 2011 |
| Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain D Ranoux, N Attal, F Morain, D Bouhassira Annals of Neurology: Official Journal of the American Neurological …, 2008 | 539 | 2008 |
| Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations X Moisset, D Bouhassira, JA Couturier, H Alchaar, S Conradi, ... Revue neurologique 176 (5), 325-352, 2020 | 515 | 2020 |
| Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations RR Edwards, RH Dworkin, DC Turk, MS Angst, R Dionne, R Freeman, ... Pain Reports 6 (1), e896, 2021 | 484 | 2021 |
| Topical clonazepam in stomatodynia: a randomised placebo-controlled study C Gremeau-Richard, A Woda, ML Navez, N Attal, D Bouhassira, ... Pain 108 (1-2), 51-57, 2004 | 415 | 2004 |
| Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? N Attal, C Fermanian, J Fermanian, M Lantéri-Minet, H Alchaar, ... Pain 138 (2), 343-353, 2008 | 413 | 2008 |
